Treat all Hepatitis B cases immediately to save lives

Hepatitis B killed 1.1 million people globally in 2024, 17% more than in 2015.

India has 30–35 million Hepatitis B cases; 5–10 million may die from cirrhosis and liver cancer.

New Asian guidelines recommend “Treat All” Hepatitis B cases instead of “Treat Select” based on viral load or fibrosis.

Generic antivirals cost less than ₹1,000 per month and can suppress the virus with minimal side effects.

India’s National Viral Hepatitis Control Programme treats less than 1 million infected people, far short of WHO 2030 targets.